FDA Alerts

pregnancy
pregnancy
10/19/2020
Nonsteroidal anti-inflammatory drugs put the fetus at risk for rare but serious kidney complications.
10/19/2020
Arthritis
Arthritis
10/01/2020
A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.
10/01/2020
FDA
FDA
07/20/2020
The US Food and Drug Administration has approved tofacitinib for the treatment of active polyarticular course juvenile idiopathic arthritis among pediatric patients aged 2 years or older.
07/20/2020
Treatment
Treatment
06/17/2020
The drug was given priority review status by the FDA and was approved to treat adults with the rare, severe autoimmune disease.
06/17/2020
FDA
FDA
04/29/2019
After the clinical trial showed positive results, the first treatment option for children with systemic lupus erythematosus has been approved.
04/29/2019
Rheumatology
Rheumatology
03/28/2019
After the clinical trial showed positive results, the first treatment option for adults with inflammatory arthritis in the spine has been approved.
03/28/2019
Rheumatologic disorders
Rheumatologic disorders
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017